ContractClinical Trial Agreement • April 10th, 2018
Contract Type FiledApril 10th, 2018AMENDMENT TO CLINICAL TRIAL AGREEMENT No. 3 DODATEK Č. 3 KE SMLOUVĚO PROVÁDĚNÍ KLINICKÉHO HODNOCENÍ This Amendment to Clinical Trial Agreement (“Amendment”) is between Fakultní nemocnice u sv. Anny v Brně having a place of business at Pekařská 664/53, 656 91 Brno, Czech Republic, Identification number: 00159816, Tax identification number: CZ00159816, represented by MUDr. Martin Pavlík, Ph.D., DESA, EDIC, Director (the “Institution”), , address:,date of birth:(Principal Investigator, hereinafter referred to as the “Investigator”) and Quintiles Czech Republic, s.r.o. Praha 5, Jinonice, Radlická 714/113a, zip code 158 00, Czech Republic, Identification number: 247 68 651,(“Quintiles”) and Boehringer Ingelheim International GmbH, having a place of business at Binger Strasse 173, 552 16 Ingelheim am Rhein, Germany (upon power of attorney represented by Quintiles Czech Republic, s.r.o.)(the “Sponsor”) and is effective as of the date last signed below. Tento dodatek ke smlouvě o provádění kli